Personalized screening panel for oncological diseases
→ materials
tissue biopsy studies, blood-based liquid biopsy
→ Methodology
immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), reverse transcription polymerase chain reaction (RT-PCR), next generation sequencing (NGS) of DNA or RNA
→ Models
Over 320 genes, mutation load analysis and microsatellite instability detection
→ Target
determination of the molecular profile for personalized maximum effective therapy, tolerance to therapy, early diagnosis of relapse
Preventive genetic panels
Diagnosis of genetic diseases
→ Models
database of 9.000 genetic diseases
→ Methodology
Next generation sequencing (NGS)
→ Diagnostic panels:
Pharmacogenomics
→ Methodology
Next generation sequencing (NGS)
→ Target
the appointment of effective drugs, taking into account the individual characteristics of the patient
→ Practical application in:
cardiology, oncology, psychiatry and in the treatment of infectious diseases
This website uses cookies.